MiMedx Group, Inc.

US$3.31As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:MDXGHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (9.41%)
Div yield —
ROE (8.53%)
Biotechnology
Beta (5Y) 1.18
PE TTM —
TSR TTM (56.73%)
Mkt cap US$483.0M
ROIC (26.79%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.02
21.36%
0.99%
Hold 2|12|4|7|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.06
0.06
0.06
0.07
17.83%
14.20%
3.30%
17.14%
Revenue$M
40.63
40.12
42.46
42.95
14.62%
10.91%
11.03%
10.94%
Peers (US$483.0M)
Cap (US$)
PE
486.7M
—
Capital
TTM
5Y
10Y
Leveragex
1.216
1.171
0.962
EBIT/Intx
2.183
0.494
0.477
Own earn%
(34.51)
(10.71)
(1.52)
Sh yield%
40.37
43.16
42.80
Owners
Insiders/Inst%
1.91
87.67
Short interest%
3.45
SBC / revenue%
2.47
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
26–34
$1 testx
0.0
Incr. ROIC%
2